Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_04-cv-02123/USCOURTS-cand-3_04-cv-02123-75/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 28:1338 Patent Infringement

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

THERASENSE, INC.,

Plaintiff,

 v.

BECTON, DICKINSON AND COMPANY,

Defendant. /

AND CONSOLIDATED CASES. 

 /

No. C 04-02123 WHA

Consolidated with

No. C 04-03327 WHA

No. C 04-03732 WHA

No. C 05-03117 WHA

ORDER RE MOTIONS FOR

WHICH ORAL ARGUMENT

WILL BE ALLOWED

Oral argument will be allowed on the following motions at the final pretrial conference:

• Bayer Motion in Limine No. 1 (Johnson Reliance on Test)

• Bayer Motion in Limine No. 3 (Reference Label)

• Roche Motion in Limine No. 2 (Standing)

• BD/Nova Motion in Limine No. 1 (Johnson and the BD Test Strips)

• BD/Nova Motion in Limine No. 2 (510(k) and Clinical Use re ’890

Patent)

• BD/Nova Motion in Limine No. 3 (To Exclude Prior Invention ’890

Patent)

• Plaintiffs’ Unnumbered Motion in Limine To Preclude Discussion or

Evidence Regarding Negotiations and Agreements

• BD/Nova Motion for Summary Judgment (’890 Patent Invalid Due to

Prior Public Use)

• Pending motions to sever

Argument time may be limited so please be prepared to make the best, brief, points. 

IT IS SO ORDERED.

Dated: May 12, 2008. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:04-cv-02123-WHA Document 733 Filed 05/12/08 Page 1 of 1